The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksExperian Regulatory News (EXPN)

Share Price Information for Experian (EXPN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,247.00
Bid: 3,246.00
Ask: 3,248.00
Change: 22.00 (0.68%)
Spread: 2.00 (0.062%)
Open: 3,256.00
High: 3,273.00
Low: 3,235.00
Prev. Close: 3,225.00
EXPN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

1 Aug 2019 12:30

RNS Number : 5608H
Experian plc
01 August 2019
 

Experian plc

 

 

Director/PDMR Notification

 

 

1 August 2019 - Experian plc, the global information services company, hereby notifies the market of the following attached individual notifications made under article 19.1 of the EU Market Abuse Regulation ('MAR').

 

This announcement is made in accordance with Article 19.3 of MAR.

 

 

1 - Details of the person discharging managerial responsibilities / person closely associated

 

 

 

Legal Person

 

Experian Finance plc (person closely associated)

 

 

 

 

2 - Reason for the notification

 

 

 

Position/status

Notification concerns a person closely associated with three PDMRs of Experian plc (Chairman - Mike Rogers, CEO - Brian Cassin and CFO - Lloyd Pitchford, who are Directors of Experian Finance plc)

 

 

Initial notification / Amendment

Initial Notification

 

 

3 - Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

 

Full name of the entity

Experian plc

 

 

Legal Entity Identifier code

635400RXXHHYT1JTSZ26

 

 

4 - Details of the transaction(s)

 

 

 

Description of the financial instrument, type of instrument

 

Ordinary shares of US 10 cents each in Experian plc

 

Identification Code

 

GB00B19NLV48

 

Nature of transaction

 

Maturity of contracts for differences, held by Experian Finance plc for the purposes of hedging the cost of the Group's employee share plans

 

Currency

 

GBP

 

Prices(s) and volumes(s)

 

Price

Volume

Total

24.96961

425,000

10,612,084.25

 

Aggregated Information

 

Price

Volume

Total

24.96961

425,000

10,612,084.25

 

Date of Transaction

 

 

2019-07-29

 

Place of transaction

 

Outside a trading venue

 

 

 

 

1 - Details of the person discharging managerial responsibilities / person closely associated

 

 

 

Legal Person

 

Experian Finance plc (person closely associated)

 

 

 

 

2 - Reason for the notification

 

 

 

Position/status

Notification concerns a person closely associated with three PDMRs of Experian plc (Chairman - Mike Rogers, CEO - Brian Cassin and CFO - Lloyd Pitchford, who are Directors of Experian Finance plc)

 

 

Initial notification / Amendment

Initial Notification

 

 

3 - Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

 

 

Full name of the entity

Experian plc

Legal Entity Identifier code

635400RXXHHYT1JTSZ26

 

4 - Details of the transaction(s)

 

 

 

Description of the financial instrument, type of instrument

 

Ordinary shares of US 10 cents each in Experian plc

 

 

Identification Code

 

GB00B19NLV48

 

 

 

Nature of transaction

 

Entry into a contract for differences by Experian Finance plc for the purposes of hedging the cost of the Group's employee share plans

 

 

 

Currency

 

GBP

 

 

 

Prices(s) and volumes(s)

 

Price

Volume

Total

24.96961

250,000

6,242,402.50

 

 

 

Aggregated Information

 

Price

Volume

Total

24.96961

250,000

6,242,402.50

 

 

 

Date of Transaction

 

 

2019-07-29

 

 

 

Place of Transaction

 

Outside a trading venue

 

 

Contact:

 

Experian

Ronan Hanna

Deputy Company Secretary

+353 (0) 1 846 9128

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHUGUAWRUPBUBG
Date   Source Headline
25th Apr 20245:16 pmRNSTransaction in Own Shares
24th Apr 20245:14 pmRNSTransaction in Own Shares
23rd Apr 20245:28 pmRNSTransaction in Own Shares
22nd Apr 20245:34 pmRNSTransaction in Own Shares
19th Apr 20245:42 pmRNSTransaction in Own Shares
18th Apr 20245:41 pmRNSTransaction in Own Shares
17th Apr 20245:21 pmRNSTransaction in Own Shares
16th Apr 20245:40 pmRNSTransaction in Own Shares
15th Apr 20245:39 pmRNSTransaction in Own Shares
12th Apr 20246:00 pmRNSTransaction in Own Shares
11th Apr 20245:42 pmRNSTransaction in Own Shares
10th Apr 20245:44 pmRNSTransaction in Own Shares
10th Apr 20249:45 amRNSAdditional Listing
9th Apr 20246:04 pmRNSTransaction in Own Shares
8th Apr 20246:14 pmRNSTransaction in Own Shares
8th Apr 20247:54 amRNSShare repurchase programme
4th Apr 20246:00 pmRNSExperian to acquire Illion in ANZ
3rd Apr 20249:30 amRNSDirector/PDMR Shareholding
28th Mar 202411:05 amRNSTotal Voting Rights
21st Mar 202412:15 pmRNSBlock listing Interim Review
20th Mar 20248:47 amRNSAdditional Listing
14th Mar 20242:08 pmRNSAdditional Listing
6th Mar 20249:15 amRNSAdditional Listing
4th Mar 202411:45 amRNSExperian signs new Revolving Credit Facility
29th Feb 202411:30 amRNSTotal Voting Rights
28th Feb 202410:15 amRNSDirector/PDMR Shareholding
28th Feb 20249:15 amRNSAdditional Listing
21st Feb 20249:15 amRNSAdditional Listing
14th Feb 20249:15 amRNSAdditional Listing
7th Feb 20249:14 amRNSAdditional Listing
6th Feb 20243:47 pmRNSDirector/PDMR Shareholding
31st Jan 202410:00 amRNSTotal Voting Rights
31st Jan 20249:20 amRNSAdditional Listing
24th Jan 20249:47 amRNSAdditional Listing
17th Jan 202412:44 pmRNSDirector/PDMR Shareholding
17th Jan 20249:44 amRNSAdditional Listing
16th Jan 20247:00 amRNSExperian Q3 FY24 trading update
12th Jan 20245:44 pmRNSFirst Interim Dividend
10th Jan 202410:55 amRNSAdditional Listing
3rd Jan 20249:02 amRNSAdditional Listing
29th Dec 202310:03 amRNSTotal Voting Rights
15th Dec 20239:32 amRNSElections for first interim dividend
13th Dec 20239:31 amRNSAdditional Listing
6th Dec 20239:14 amRNSAdditional Listing
30th Nov 202312:14 pmRNSTotal Voting Rights
29th Nov 20239:43 amRNSAdditional Listing
22nd Nov 20239:25 amRNSAdditional Listing
15th Nov 20237:00 amRNSHalf-year Report
10th Nov 20239:00 amRNSDirector Declaration
31st Oct 20235:04 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.